12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

TNI BioTech, LDN Research deal

TNI BioTech received exclusive rights to patents developed by Dr. Jill Smith and LDN relating to treatments for opioid antagonists, such as naltrexone, to treat inflammatory and ulcerative diseases of...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >